KO:NYSECoca-Cola Company (The) Analysis
Data as of 2026-09-11 - not real-time
$87.83
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
The Coca-Cola Company is priced at $87.83 and its moving averages line up in bullish order, the shorter sitting above the longer. The last 30 days have lost 1.4%. With RSI at 49.1 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $86.85 and resistance around $92.49.
Multiples put this in overvalued territory at a P/E of 26.3. Consensus targets land 7.8% above where the shares trade now. Revenue is growing at 6.7% on a 28.6% profit margin. The 2.42% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 13.8%, a beta of -0.26 and a maximum drawdown of 8.5%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 3/10 conviction over the longer horizon.
Multiples put this in overvalued territory at a P/E of 26.3. Consensus targets land 7.8% above where the shares trade now. Revenue is growing at 6.7% on a 28.6% profit margin. The 2.42% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 13.8%, a beta of -0.26 and a maximum drawdown of 8.5%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 3/10 conviction over the longer horizon.
Top Market Events
Chris Lange Sep 3, 2026 0 Thinkstock Quick Read - KO's 60-year dividend streak earns an A+, but 27% YTD price...The Coca-Cola Company NYSE:KO has been having a good year.Coca-Cola stock is trading close to recent highs as Q2 2026 results show double-digit EPS growth and
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 78.70
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 78.70
- Analyst targets imply +7.8% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Analyst targets imply +7.8% versus the current price
- Profit margin of 28.6% is healthy
- P/E ratio of 26.3
Key Metrics & Analysis
Financial Health
Revenue Growth6.70%
Profit Margin28.56%
P/E Ratio26.3
ROE42.05%
ROA9.40%
Debt/Equity115.52
P/B Ratio10.5
Op. Cash Flow$16.3B
Free Cash Flow$5.2B
Technical Analysis
TrendBullish
RSI49.1
Support$86.85
Resistance$92.49
MA 20$89.04
MA 50$86.41
MA 200$78.70
MACDBearish
VolumeIncreasing
Fear & Greed Index89.82
Valuation
Fair Value$13.76
Target Price$94.70
Upside/Downside7.82%
GradeOvervalued
TypeBlend
Dividend Yield2.42%
Risk Assessment
Beta-0.26
Volatility13.76%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.